Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Goldman Adds BHP Billiton To Conviction Buy List

Thu, 15th Jan 2015 09:49

LONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
GOLDMAN SACHS RAISES BHP BILLITON TO 'CONVICTION BUY LIST' ('NEUTRAL') - PRICE TARGET 1575 (1870) PENCE
----------
NOMURA CUTS BG GROUP PRICE TARGET TO 900 (1000) PENCE - 'REDUCE'
----------
JEFFERIES CUTS BG GROUP PRICE TARGET TO 1215 (1250) PENCE - 'BUY'
----------
NOMURA CUTS BP PRICE TARGET TO 380 (430) PENCE - 'NEUTRAL'
----------
JEFFERIES CUTS BP PRICE TARGET TO 470 (490) PENCE - 'BUY'
----------
JEFFERIES CUTS SHELL A PRICE TARGET TO 2450 (2540) PENCE - 'BUY'
----------
NOMURA CUTS SHELL B PRICE TARGET TO 2350 (2600) PENCE - 'BUY'
----------
S&P CAPITAL IQ CUTS BHP BILLITON TO 'HOLD' ('BUY') - PRICE TARGET 1300 (1825) PENCE
----------
UBS CUTS BHP BILLITON PRICE TARGET TO 1870 (2000) PENCE - 'BUY'
----------
BARCLAYS CUTS BHP BILLITON PRICE TARGET TO 1500 (2100) PENCE - 'OVERWEIGHT'
----------
S&P CAPITAL IQ RAISES BURBERRY PRICE TARGET TO 1520 (1420) PENCE - 'SELL'
----------
TRADERS: NUMIS CUTS ANTOFAGASTA TO 'REDUCE' ('HOLD')
----------
S&P CAPITAL IQ CUTS ANTOFAGASTA TO 'SELL' ('HOLD') - TARGET 625 (760) PENCE
----------
BARCLAYS CUTS ANTOFAGASTA PRICE TARGET TO 700 (745) PENCE - 'EQUAL WEIGHT'
----------
S&P CAPITAL IQ CUTS RIO TINTO PRICE TARGET TO 2800 (3300) PENCE - 'HOLD'
----------
UBS CUTS RIO TINTO PRICE TARGET TO 3300 (3500) PENCE - 'BUY'
----------
BERNSTEIN RAISES RBS PRICE TARGET TO 470 (450) PENCE - 'OUTPERFORM'
----------
BARCLAYS CUTS ANGLO AMERICAN PRICE TARGET TO 1080 (1550) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES FRESNILLO PRICE TARGET TO 835 (800) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES RANDGOLD RESOURCES TARGET TO 5600 (4900) PENCE - 'OVERWEIGHT'
----------
TRADERS: NUMIS CUTS RANDGOLD RESOURCES TO 'HOLD' ('BUY')
----------
BARCLAYS RAISES COMPASS GROUP PRICE TARGET TO 1250 (1180) PENCE - 'OVERWEIGHT'
----------
CS CUTS COMPASS GROUP TO 'NEUTRAL' ('OUTPERFORM') - TARGET 190 PENCE
----------
BARCLAYS RAISES INTERCONTINENTAL HOTELS TARGET TO 2650 (2360) PENCE; 'EQUAL WEIGHT.'
----------
BARCLAYS RAISES WHITBREAD PRICE TARGET TO 5400 (4900) PENCE - 'OVERWEIGHT'
----------
Investec Raises BAT Price Target To 3,600P From 3,400P, Keeps At Hold
----------
EXANE BNP CUTS SKY PLC TO 'NEUTRAL' ('OUTPERFORM') - PRICE TARGET 1000 (985) PENCE
----------
EXANE BNP RAISES GKN PRICE TARGET TO 380 (340) PENCE - 'OUTPERFORM'
----------
EXANE BNP CUTS SMITHS GROUP PRICE TARGET TO 1050 (1150) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS WEIR GROUP PRICE TARGET TO 1500 (1835) PENCE - 'UNDERPERFORM'
----------
DEUTSCHE BANK RAISES ASTRAZENECA PRICE TARGET TO 4800 (4350) PENCE - 'HOLD'
----------
DEUTSCHE BANK CUTS GLAXOSMITHKLINE PRICE TARGET TO 1300 (1390) PENCE - 'HOLD'
----------
HSBC RAISES EASYJET PRICE TARGET TO 1500 (1450) PENCE - 'UNDERWEIGHT'
----------
HSBC CUTS ADMIRAL GROUP PRICE TARGET TO 1590 (1625) PENCE - 'OVERWEIGHT'
----------
HSBC CUTS RSA INSURANCE PRICE TARGET TO 474 (480) PENCE - 'NEUTRAL'
----------
HSBC CUTS AVIVA PRICE TARGET TO 535 (590) PENCE - 'NEUTRAL'
----------
HSBC RAISES PRUDENTIAL PRICE TARGET TO 1800 (1725) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES DIRECT LINE PRICE TARGET TO 346 (335) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES FRIENDS LIFE PRICE TARGET TO 420 (415) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES LEGAL & GENERAL PRICE TARGET TO 296 (285) PENCE - 'OVERWEIGHT'
----------
HSBC CUTS STANDARD LIFE PRICE TARGET TO 425 (430) PENCE - 'NEUTRAL'
----------
FTSE 250
----------
JPMORGAN RAISES REDEFINE INTERNATIONAL TARGET TO 53 (50) PENCE - 'UNDERWEIGHT'
----------
BERENBERG INITIATES BODYCOTE WITH 'HOLD' - TARGET 684 PENCE
----------
SOCGEN RAISES PROVIDENT FINANCIAL PRICE TARGET TO 2540 (2270) PENCE - 'HOLD'
----------
TRADERS: NUMIS CUTS KAZ MINERALS TO 'REDUCE' ('HOLD')
----------
BARCLAYS CUTS KAZ MINERALS PRICE TARGET TO 150 (255) PENCE - 'EQUAL WEIGHT'
----------
CREDIT SUISSE RAISES LADBROKES TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 115 PENCE
----------
BARCLAYS CUTS LADBROKES PRICE TARGET TO 104 (126) PENCE - 'EQUAL WEIGHT'
----------
CREDIT SUISSE CUTS DOMINO'S PIZZA TO 'NEUTRAL' ('OUTPERFORM') - TARGET 695 (650) PENCE
----------
TRADERS: CITIGROUP RAISES JUPITER FUND TO 'BUY' ('NEUTRAL')
----------
BARCLAYS CUTS LONMIN PRICE TARGET TO 155 (190) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS RAISES ACACIA MINING TO 'OVERWEIGHT' ('EQUAL WEIGHT')
----------
BARCLAYS CUTS PETRA DIAMONDS PRICE TARGET TO 280 (290) PENCE - 'OVERWEIGHT'
----------
BARCLAYS RAISES POLYMETAL TO 'EQUAL WEIGHT' ('UNDERWEIGHT')
----------
BARCLAYS CUTS VEDANTA PRICE TARGET TO 400 (840) PENCE - 'UNDERWEIGHT'
----------
EXANE BNP RAISES TALK TALK TELECOM TARGET TO 220 (200) PENCE - 'UNDERPERFORM'
----------
BARCLAYS RAISES MERLIN ENTERTAINMENTS TARGET TO 450 (420) PENCE - 'OVERWEIGHT'
----------
BARCLAYS CUTS WILLIAM HILL PRICE TARGET TO 390 (400) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS CUTS MARSTONS TO 'UNDERWEIGHT' ('EQUAL WEIGHT') - TARGET 130 (150) PENCE
----------
EXANE BNP RAISES HALMA TO 'OUTPERFORM' ('NEUTRAL') - TARGET 780 (685) PENCE
----------
EXANE BNP RAISES ROTORK TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 2300 PENCE
----------
EXANE BNP CUTS SPECTRIS TO 'UNDERPERFORM' ('NEUTRAL') - TARGET 1825 (1740) PENCE
----------
EXANE BNP RAISES SPIRAX-SARCO TO 'NEUTRAL' ('UNDERPERFORM')
----------
EXANE BNP RAISES SPIRAX-SARCO TARGET TO 2935 (2450) PENCE
----------
EXANE BNP RAISES VESUVIUS TO 'OUTPERFORM' ('NEUTRAL') - TARGET 510 (440) PENCE
----------
BARCLAYS RAISES BETFAIR PRICE TARGET TO 1626 (1576) PENCE - 'OVERWEIGHT'
----------
SOCGEN RAISES BBA AVIATION PRICE TARGET TO 400 (360) PENCE - 'BUY'
----------
HSBC CUTS CATLIN GROUP TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 720 (620) PENCE
----------
HSBC CUTS PHOENIX GROUP TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 875 (870) PENCE
----------
HSBC RAISES AMLIN PRICE TARGET TO 433 (420) PENCE - 'UNDERWEIGHT'
----------
HSBC RAISES ESURE GROUP PRICE TARGET TO 330 (320) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES HISCOX PRICE TARGET TO 715 (690) PENCE - 'NEUTRAL'
----------
HSBC RAISES LANCASHIRE HLDGS PRICE TARGET TO 655 (650) PENCE - 'OVERWEIGHT'
----------
MAIN MARKET AND AIM
----------
UBS CUTS FENNER PRICE TARGET TO 210 (235) PENCE - 'NEUTRAL'
----------
UBS CUTS PREMIER OIL PRICE TARGET TO 200 (300) PENCE - 'BUY'
----------
TRADERS: NUMIS CUTS PETROPAVLOVSK TO 'SELL' ('REDUCE')
----------
BARCLAYS CUTS FERREXPO TO 'UNDERWEIGHT' ('EQUAL WEIGHT.') - TARGET 50 (140) PENCE
----------
BARCLAYS CUTS GEM DIAMONDS PRICE TARGET TO 245 (260) PENCE - 'OVERWEIGHT'
----------
BARCLAYS RAISES HOCHSCHILD MINING TO 'OVERWEIGHT' ('EQUAL WEIGHT')
----------
PANMURE RAISES SQS SOFTWARE PRICE TARGET TO 590 (527) PENCE - 'HOLD'
----------
HSBC RAISES FLYBE GROUP PRICE TARGET TO 150 (140) PENCE - 'OVERWEIGHT'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.